These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1665321)

  • 21. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions.
    Peggs K; Verfuerth S; Mackinnon S
    Blood; 2001 Feb; 97(4):994-1000. PubMed ID: 11159528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.
    Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P
    J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease.
    Odendahl M; Grigoleit GU; Bönig H; Neuenhahn M; Albrecht J; Anderl F; Germeroth L; Schmitz M; Bornhäuser M; Einsele H; Seifried E; Busch DH; Tonn T
    Cytotherapy; 2014 Sep; 16(9):1245-56. PubMed ID: 25108651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of humoral immunity against cytomegalovirus proteins following transplantation of T-cell-depleted allogeneic bone marrow from seropositive donors.
    Roy DM; Brenner MK; Cook D; Duncan RI; Griffiths PD; Grundy JE
    J Med Virol; 1993 Oct; 41(2):150-8. PubMed ID: 8283177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?
    García-Ríos E; Nuévalos M; Mancebo FJ; Pérez-Romero P
    Front Immunol; 2021; 12():657144. PubMed ID: 33968058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
    J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive immunotherapy for cytomegalovirus (CMV) disease in immunocompromised patients.
    Lim JB; Kwon OH; Kim HS; Kim HO; Choi JR; Provenzano M; Stroncek D
    Yonsei Med J; 2004 Jun; 45 Suppl():18-22. PubMed ID: 15250045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients.
    Lolli F; Sundqvist VA; Castagna A; Ljungman P; Linde A; Andersson G; Olsson T; Wahren B
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):55-62. PubMed ID: 8395936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous Adoptive T-cell Therapy for Recurrent or Drug-resistant Cytomegalovirus Complications in Solid Organ Transplant Recipients: A Single-arm Open-label Phase I Clinical Trial.
    Smith C; Beagley L; Rehan S; Neller MA; Crooks P; Solomon M; Holmes-Liew CL; Holmes M; McKenzie SC; Hopkins P; Campbell S; Francis RS; Chambers DC; Khanna R
    Clin Infect Dis; 2019 Feb; 68(4):632-640. PubMed ID: 29982441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.
    Riddell SR
    Semin Respir Infect; 1995 Dec; 10(4):199-208. PubMed ID: 8668847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
    Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
    Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients.
    Dolstra H; Van de Wiel-van Kemenade E; De Witte T; Preijers F
    Bone Marrow Transplant; 1996 Aug; 18(2):339-45. PubMed ID: 8864444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression.
    Riddell SR; Rabin M; Geballe AP; Britt WJ; Greenberg PD
    J Immunol; 1991 Apr; 146(8):2795-804. PubMed ID: 1707922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.
    Cobbold M; Khan N; Pourgheysari B; Tauro S; McDonald D; Osman H; Assenmacher M; Billingham L; Steward C; Crawley C; Olavarria E; Goldman J; Chakraverty R; Mahendra P; Craddock C; Moss PA
    J Exp Med; 2005 Aug; 202(3):379-86. PubMed ID: 16061727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy.
    Spielmann G; Bollard CM; Kunz H; Hanley PJ; Simpson RJ
    Sci Rep; 2016 May; 6():25852. PubMed ID: 27181409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.